ORPHA:1160
Chylous ascites
Clinical definition (Orphanet)
Chylous ascites is a rare form of ascites caused by accumulation of lymph in the peritoneal cavity, usually due to intra-abdominal malignancy, liver cirrhosis or abdominal surgery complications, and present with painless but abdominal distension, dyspnea and weight gain.
How rare: How common this is has not been clearly measured.
Is anyone studying this?
3,913
3,913 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=183) is 38.
3,913 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 38 (publications denominator n=183).
1,801 in the last 10 years · low confidence
Is a treatment being tested?
1
trials for this specific condition
1 interventional trial matched this specific condition name; none in our sample are currently recruiting.
Data as of 26 July 2026
1 interventional trial — more than 59.2% of diseases in the trials denominator have none at all (151 of 255; this disease is at the 65.3th percentile).
low confidence · 65.3th percentile (trials denominator)
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Who's working on it?
1,131
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Kato M10 papers · 2026
Department of Pediatric Surgery, Keio University School of Medicine, Tokyo, Japan.
Papers in Europe PMC - 02Takahashi M7 papers · 2026
Department of Medical Oncology, Tohoku University Hospital, Sendai 980-8547, Japan.
Papers in Europe PMC - 03Aoki Y6 papers · 2026
Department of Gynecologic Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo 135-8550 Japan.
Papers in Europe PMC - 04Kamata M6 papers · 2026
Department of Gynecologic Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo 135-8550 Japan.
Papers in Europe PMC - 05Nakajima Y6 papers · 2026
Division of Pediatric Endocrinology, Metabolism and Nephrology, Children's Medical Center, Osaka City General Hospital, Osaka 534-0021, Japan.
Papers in Europe PMC - 06Ogawa K6 papers · 2026
Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Papers in Europe PMC - 07
- 08Tanaka K6 papers · 2026
Department of General and Gastroenterological Surgery, Showa Medical University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.
Papers in Europe PMC - 09Akita S5 papers · 2026
Department of Plastic Surgery, Tamaki Aozora Hospital, Tokushima City, Japan.
Papers in Europe PMC - 10Arai Y5 papers · 2026
Department of Pediatric Surgery, Niigata University, Niigata City, Japan.
Papers in Europe PMC
Recruiting interventional trials
Trials testing a treatment from the matched ClinicalTrials.gov set
1 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored below but are not added to the query string.
"Chylous ascites"
MeSH descriptor terms unioned into the query: Chylous Ascites
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Chylous ascites"
Interventional trials matched via: both (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 1 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Cross-references (from Mondo): MESH:D002915 OMIM:208300 UMLS:C0008732 NCIT:C34482
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (3913) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity